# BioLineRx Ltd.: Form SC 13D, filed Aug 8, 2017

- Company: [BioLineRx Ltd.](/companies/blrx.md) (CIK 1498403)
- Form: SC 13D
- Filed: 2017-08-08
- Accepted by EDGAR: Aug 8, 2017, 00:29 ET
- Period: not reported
- Accession: 0000921895-17-002050
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1498403/000092189517002050/sc13d07422010_08072017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1498403/000092189517002050/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1498403/000092189517002050/sc13d07422010_08072017.htm

Filed Aug 8, 2017.
Source: SEC EDGAR, the filing index for accession 0000921895-17-002050. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
